Allogeneic HSCT

INCHEON, South Korea, July 1, 2026 Samsung Bioepis has officially announced the U.S. relaunch of BYOOVIZ® (ranibizumab-nuna), the first...

SILVER SPRING, Md., June 30, 2026 The U.S. Food and Drug Administration (FDA) has approved Tregzi, the first regulatory...